On the stock market since 2021, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades 43% below its peak. The market has trimmed its expectations for the company.
It pays out $0.29 per share each year — regular cash for whoever holds the stock.
A loss of $220K against $0 in annual sales.
The stock sits at $0.40. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, PAFOR sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: PAFOR is a high-risk stock — not yet profitable, and its future rides on its product catching on.